J. Vergis and R. E. McCullumsmith, “Pathway enrichment and FDA-approved drug repurposing analysis for the treatment of CTNNB1 Syndrome modeled in an SH-SY5Y cell line”, Translation, vol. 14, no. S1, Oct. 2025, doi: 10.46570/utjms-2025-1507.